epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Antara
    fenofibrate micronized
  • remove guanfacine
    generic
  • remove Suboxone
    buprenorphine/ naloxone
  • remove Vantin
    cefpodoxime proxetil

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face guanfacine (generic) + Suboxone (buprenorphine/ naloxone)

Monitor/Modify Tx


guanfacine + buprenorphine

monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

Additional Considerations

Smiley face Smiley face buprenorphine in Suboxone

consider prescribing an opioid overdose reversal agent, especially with concomitant CNS depressant use

Smiley face Smiley face naloxone (abuse deterrent) in Suboxone

no pharmacologic activity when administered as directed

Smiley face Smiley face cefpodoxime in Vantin

cefpodoxime proxetil (prodrug) converted to cefpodoxime

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback Cookie Preferences
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information